Hydroxychloroquine plus standard of care compared with standard of care alone in COVID-19: a meta-analysis of randomized controlled trials

The efficacy and safety of Hydroxychloroquine (HCQ) in treating coronavirus disease (COVID-19) is disputed. This systematic review and meta-analysis aimed to examine the efficacy and safety of HCQ in addition to standard of care (SOC) in COVID-19. PubMed, the Cochrane Library, Embase, Web of science...

Descripción completa

Detalles Bibliográficos
Autores principales: Amani, Bahman, Khanijahani, Ahmad, Amani, Behnam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184930/
https://www.ncbi.nlm.nih.gov/pubmed/34099745
http://dx.doi.org/10.1038/s41598-021-91089-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184930/
https://www.ncbi.nlm.nih.gov/pubmed/34099745
http://dx.doi.org/10.1038/s41598-021-91089-3

Ejemplares similares